Role of intrarenal angiotensin II in glucocorticoid-induced renal vasodilation

Clinical and Experimental Nephrology

Volumn 5, Issue 3, 2001, Pages 186-192

  Kubota, E ^a   Hayashi, K ^a   Matsuda, H ^a   Honda, M ^a   Tokuyama, H ^a   Okubo, K ^a   Naitoh, M ^a   Arakawa, K ^a   Saruta, T ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Angiotensin converting enzyme; Conscious dogs; Glucocorticoids; Renal hemodynamics

Indexed keywords

ANGIOTENSIN; CANDESARTAN; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOCORTICOID;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; HYPERTENSION; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; VASODILATATION;

EID: 0034748384     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101570170009     Document Type: Article

References (32)

1. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome
2. Depressor systems contribute to hypertension induced by glucocorticoid excess in dogs
3. Dexamethasone hypertension in rats: Role of prostaglandins and pressor sensitivity to norepinephrine
4. Dexamethasone inhibits nitric oxide synthase mRNA induction by interleukin-1 alpha and tumor necrosis factoralpha in vascular smooth muscle cells
5. Glucocorticoids and control of glomerular filtration rate
6. Effect of methylprednisolone on renal function and the zonal distribution of blood flow in the rat
7. Control of arterial pressure and renal function during glucocorticoid excess in dogs
8. Chronic effects of ACTH and cortisol excess on arterial pressure in normotensive and hypertensive dogs
9. Zonal heterogeneity in action of angiotensin-converting enzyme inhibitor on renal microcirculation: Role of intrarenal bradykinin
10. Effects of oral AVP receptor antagonists OPC21268 and OPC-31260 on congestive heart failure in conscious dogs
11. Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension
12. Evaluation of a test kit for the rapid and simple colorimetric measurement of angiotensin Iconverting enzyme in serum
13. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism
14. Autoregulation and tubuloglomerular feedback in juxtamedullary glomerular arterioles
15. Effect of methylprednisolone upon arterial pressure and the renin angiotensin system in the rat
16. Proximal tubular secretion of angiotensin II in rats
17. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat
18. Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition
19. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule
20. Corticosteroids decrease glomerular angiotensin receptors
21. Superficial nephron responses to peritubular capillary infusions of angiotensins I and II
22. Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics
23. Regulation of angiotensin II receptor subtypes by dexamethasone in rat mesangial cells
24. Increased expression of vascular angiotensin II type 1A receptor gene in glucocorticoid-induced hypertension
25. Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron
26. Intrarenal production of angiotensin II
27. Angiotensin II in arterial and renal venous plasma and renal lymph in the dog
28. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle
29. Glucocorticoid-induced renal vasodilatation is mediated by a direct renal action involving nitric oxide
30. Inhibition of prostaglandin and nitric oxide synthesis prevents cortisol-induced renal vasodilation in sheep
31. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney
32. Effects of physiological infusion of atrial natriuretic factor on healthy subjects and patients with the nephrotic syndrome